Melatonin adds a small amount of sleep on average for people with dementia and does not have strong proof for calming sundowning. Sundowning means restlessness, agitation, irritability or confusion that starts or worsens as daylight fades. The National Institute on Aging says Alzheimer-related brain changes can disrupt the internal clock and confuse sleep-wake cycles. Triggers such as being overtired, hunger, pain, depression or boredom can then set off evening distress.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Why do evenings become difficult?
- How much does sleep improve?
- Does evening agitation improve?
- What are the risks for older adults?
- How should caregivers discuss a trial?
Why do evenings become difficult?
The National Institute on Aging describes sundowning as restlessness, agitation, irritability or confusion that begins as daylight fades and can continue into night. The same source links it to Alzheimer-related changes in the internal biological clock.
An overtired person may pace, argue, or resist care after dinner. Hunger, pain, depression or boredom can add to the confusion. A missed nap, a noisy room, or a late meal can tip the evening.
How much does sleep improve?
The Cochrane Dementia Group found low-certainty evidence of little or no effect on major sleep outcomes with melatonin up to 10 mg nightly for 8-10 weeks in Alzheimer's with sleep disturbance, reported in the Cochrane review. That review covered the strongest controlled sleep measures. An ICH GCP summary of a PubMed meta-analysis of 7 randomized trials in 520 people with dementia reported 24.36 minutes more total sleep than placebo, described in the trial summary.
The gain was small on average and reached statistical significance. A gain near 24 minutes does not mean a full night of steady sleep. Some people gain more, some gain nothing, and nighttime waking can persist.
Does evening agitation improve?
Neuro Endocrinology Letters reported small open-label studies in which 7 of 10 dementia patients given 3 mg at bedtime for 3 weeks had less sundowning and less variable sleep onset. Evening restlessness eased for most patients in that tiny group.
Open-label care without a placebo can overstate benefit. The result points to possible help for selected patients, not a reliable treatment for sundowning.
What are the risks for older adults?
The National Center for Complementary and Integrative Health notes short-term melatonin appears safe for most adults, with mild headache, dizziness, nausea and sleepiness, explained on its melatonin safety page. The same source says long-term safety is unproven and melatonin may stay active longer in older adults.
The American Academy of Sleep Medicine's 2015 circadian-rhythm guideline recommended against melatonin for elderly people with dementia because of fall risk and uncertain benefit. The Alzheimer's Drug Discovery Foundation summarized that guidance in a 2023 update. Watch for these problems during any use:.
- daytime drowsiness or morning grogginess
- dizziness, unsteadiness, or a fall
- headache, nausea, or new daytime sleepiness
How should caregivers discuss a trial?
Mayo Clinic advises melatonin may help sleep and reduce sundowning in dementia, often discussed as 0.5-3 mg taken 1-2 hours before bed with clinician approval because evidence is mixed, stated in its caregiver guidance. A clinician can weigh sleep needs against fall risk and other drugs. Bring a clear record and ask direct questions: Bring the pill bottle to that visit so the clinician sees the exact dose.
- share a one-week log of bedtime, wake time, naps, and evening agitation
- list pain, hunger, mood changes, and recent illness
- ask about dose, timing, duration, and when to stop
